SEC Form 4 · accession 0001213900-19-003749
Hoth Therapeutics, Inc. · RKTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David S. Briones
Officer — Chief Financial Officer
Period of report
Mar 6, 2019
Accepted (ET)
Mar 7, 2019 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001711786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options | $5.88 | Mar 6, 2019 | J | 50,000 | A | Mar 6, 2019 | Mar 6, 2024 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F1The options were issued pursuant to the Issuer's 2018 Equity Incentive Plan and vested in full upon grant.